ACTRN12614000727640招募中2 期
Haemodynamic effects of Milrinone in patients with heart failure and preserved ejection fraction (HFPEF)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Adults greater than or equal to 18 years of age, AND
- •Symptoms of HF (NYHA II-III) AND
- •Normal ejection fraction (LVEF equal to and more than 45%) with evidence of diastolic dysfunction as prescribed by ESC Working Group 15 (resting PCWP more than 12; E/e’ more than 15 or Eand e prime more than 8 and
- •and NT-BNP more than 220)
排除标准
- •Other cause for dyspnoea including moderate or severe valvular HD and pulmonary hypertension with PVR more than 4 Wood Units
- •Body mass index (BMI) more than 35 kg/m2
- •History of stress-induced syncope or ventricular tachycardia during exercise
- •Unstable coronary artery disease
- •Symptoms and signs of congestive heart failure at rest (NYHA IV)
- •Unable to perform exercise test
研究者
相似试验
招募中
2 期
Effect of Milrinonein treatment vasospasm in patients with ?subarachnoid hemorrhagesubarachnoid hemorrhage.Nontraumatic subarachnoid hemorrhageIRCT20141209020258N82Arak University of Medical Sciences32
已完成
不适用
The effect of milrinone on induced hypotensive anesthesia for elderly patientsKCT0000313The Catholic University of Korea, Seoul St. Mary's Hospital60
招募中
不适用
Pharmacokinetics of milrinone with congestive heart failureJPRN-UMIN000048102agoya University Graduate School of Medicine100
尚未招募
Unknown
बाà¤?à¤? निलय à¤?à¥? शिथिलता वालà¥? रà¥?à¤?ियà¥?à¤? मà¥?à¤? बिना पमà¥?प à¤?à¥? सहायता à¤?à¥? दिल à¤?à¥? धमिनयà¥?à¤? à¤?à¥? शलà¥?य à¤?िà¤?ितà¥?सा à¤?à¥? दà¥?रान à¤?म à¤?à¥?राà¤? मà¥?à¤? मिलरà¥?नà¥?न दवा à¤?à¥? निवारà¤? à¤à¥?मिà¤?ाCTRI/2020/01/022851GB pant institute of postgraduate medical education and research
已完成
3 期
Comparison of the effect of milrinone and dobutamine on pulmonary hypertensioPulmonary hypertension.Other secondary pulmonary hypertensionI27.2IRCT20211102052941N1Esfahan University of Medical Sciences38